ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Mergers & Acquisitions

DSM buys Erber’s animal nutrition firm for $1 billion

by Melody M. Bomgardner
June 20, 2020 | APPEARED IN VOLUME 98, ISSUE 24

DSM has agreed to purchase Austria’s Erber Group for $1.1 billion. The deal continues DSM’s shift in focus from industrial chemicals to ingredients for nutrition and health markets. Erber owns Biomin and Romer Labs, which specialize in mycotoxin risk management, gut health, and diagnostics that track animal feed safety and quality. Biomin sells enzymes and adsorbents that bind and break down toxins such as aflatoxins and ergot alkaloids present in feed. Other products include gut health–promoting phytogenic and mineral feed additives, probiotics, and acidifiers. Diagnostics from Romer detect mycotoxins, food allergens and pathogens, and genetically modified organisms. Biomin and Romer have combined annual sales of $370 million and 1,200 employees. In April, DSM completed its acquisition of Glycom, a supplier of human milk oligosaccharides, for $860 million. In a review prompted by the Erber deal, the credit rating agency Moody’s said “animal health and nutrition-related businesses are amongst the most resilient end markets of chemical companies.”

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment